Literature DB >> 2227992

Tolerance in vivo and in vitro.

K Tomonari1.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2227992     DOI： 10.1111/j.1600-065x.1990.tb00808.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  9 in total

1.  Positive selection of Tcrb-V10b+ T cells.

Authors:  K Tomonari; R Hederer; H Hengartner
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  The genetic basis of negative selection of Tcrb-V11+ T cells.

Authors:  K Tomonari; S Fairchild
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Negative selection of Tcra-V8+CD8+ T cells by MHC class I molecules.

Authors:  K Tomonari
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

4.  Co-segregation of a gene encoding a deletion ligand for Tcrb-V3+ T cells with Mtv-3.

Authors:  S Fairchild; A M Knight; P J Dyson; K Tomonari
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

5.  Correlation between the V beta 4+ CD8+ T-cell population and the H-2d haplotype.

Authors:  K Tomonari; E Lovering; S Spencer
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Linkage between Tcrb-V and a gene responsible for deletion of Tcrb-V11+ T cells.

Authors:  K Tomonari
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

7.  Positive and negative selection of Tcrb-V6+ T cells.

Authors:  K Tomonari; S Fairchild
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

8.  Tcrb-V3+ T-cell deletion and a new mouse mammary tumor provirus, Mtv-44.

Authors:  S Fairchild; O A Rosenwasser; P J Dyson; K Tomonari
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

9.  Interleukin 2 abrogates the nonresponsive state of T cells expressing a forbidden T cell receptor repertoire and induces autoimmune disease in neonatally thymectomized mice.

Authors:  J L Andreu-Sánchez; I M Moreno de Alborán; M A Marcos; A Sánchez-Movilla; C Martínez-A; G Kroemer
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.